American Journal of Ophthalmology
Volume 150, Issue 3 , Pages 295-304.e1 , September 2010

Evaluating Exaggerated, Prolonged, or Delayed Postoperative Intraocular Inflammation

  • Rishi R. Doshi

      Affiliations

    • Department of Ophthalmology, California Pacific Medical Center, San Francisco, California
  • ,
  • J. Fernando Arevalo

      Affiliations

    • Retina and Vitreous Service, Clínica Oftalmológica Centro Caracas, Caracas, Venezuela
  • ,
  • Harry W. Flynn Jr.

      Affiliations

    • The Bascom Palmer Eye Institute, University of Miami, Miami, Florida
  • ,
  • Emmett T. Cunningham Jr.

      Affiliations

    • Department of Ophthalmology, California Pacific Medical Center, San Francisco, California
    • Department of Ophthalmology, Stanford University School of Medicine, Stanford, California
    • Corresponding Author InformationInquiries to Emmett T. Cunningham, Jr., West Coast Retina Medical Group, 185 Berry Street, Lobby 2, Suite 130, San Francisco, CA 94107

,Accepted 12 April 2010.

References 

  1. Foster A. Cataract and “Vision 2020-the right to sight” initiative. Br J Ophthalmol. 2001;85(6):635–637
  2. Brian G, Taylor H. Cataract blindness—challenges for the 21st century. Bull World Health Organ. 2001;79(3):249–256
  3. Etzioni DA, Liu JH, Maggard MA, Ko CY. The aging population and its impact on the surgery workforce. Ann Surg. 2003;238(2):170–177
  4. Vaudaux JD, Eperon S, Nguyen C, Guex-Crosier Y. Inflammation in cataract surgery. Expert Rev Ophthalmol. 2007;2(5):803–818
  5. Donnenfeld ED, Holland EJ, Stewart RH, Gow JA, Grillone JR. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Ophthalmology. 2007;114(9):1653–1662
  6. Korenfeld MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg. 2009;35(1):26–34
  7. Lalwani GA, Flynn HW, Scott IU, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996–2005) (Clinical features, causative organisms, and visual acuity outcomes). Ophthalmology. 2008;115(3):473–476
  8. Narang S, Gupta A, Gupta V, et al. Fungal endophthalmitis following cataract surgery: clinical presentation, microbiological spectrum, and outcome. Am J Ophthalmol. 2001;132(5):609–617
  9. Johnson MW, Doft BH, Kelsey SF, et al. The Endophthalmitis Vitrectomy Study: relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997;104(2):261–272
  10. Ramakrishnan R, Bharathi MJ, Shivkumar C, et al. Microbiological profile of culture-proven cases of exogenous and endogenous endophthalmitis: a 10-year retrospective study. Eye. 2009;23(4):945–956
  11. Eifrig CW, Scott IU, Flynn HW, Miller D. Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology. 2003;110(9):1714–1717
  12. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996;122(6):830–846
  13. Pijl BJ, Theelen T, Tilanus MA, Rentenaar R, Crama N. Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands. Am J Ophthalmol. 2010;149(3):482–487
  14. Mamalis N, Edelhauser HF, Dawson DG, Chew J, LeBoyer RM, Werner L. Toxic anterior segment syndrome. J Cataract Refract Surg. 2006;32(2):324–333
  15. Holland SP, Morck DW, Lee TL. Update on toxic anterior segment syndrome. Curr Opin Ophthalmol. 2007;18(1):4–8
  16. Berrocal AM, Davis JL. Uveitis following intraocular surgery. Ophthalmol Clin North Am. 2002;15(3):357–364
  17. Laurell CG, Zetterstrom C. Inflammation and blood-aqueous-barrier disruption. J Cataract Refract Surg. 2000;26(3):306–307
  18. McGhee CN, Ormonde S. Endophthalmitis after contemporary cataract surgery: defining incidence and risk factors. Clin Experiment Ophthalmol. 2003;31(3):176–178
  19. Al-Mezaine HS, Kangave D, Al-Assiri A, Al-Rajhi AA. Acute-onset nosocomial endophthalmitis after cataract surgery: incidence, clinical features, causative organisms, and visual outcomes. J Cataract Refract Surg. 2009;35(4):643–649
  20. Major JC, Engelbert M, Flynn HW, et al. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol. 2010;149(2):278–283
  21. Eifrig CW, Scott IU, Flynn HW, Smiddy WE, Newton J. Endophthalmitis after pars plana vitrectomy: incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol. 2004;138(5):799–802
  22. Cohen MS, Flynn HW, Murray TG, Smiddy WE. Endophthalmitis after pars plana vitrectomy. Ophthalmology. 1995;102(5):705–712
  23. Schaal S, Barr CC. Management of retained lens fragments after cataract surgery with and without pars plana vitrectomy. J Cataract Refract Surg. 2009;35(5):863–867
  24. Wilkinson CP, Green WR. Vitrectomy for retained lens material after cataract extraction: the relationship between histopathologic findings and the time of vitreous surgery. Ophthalmology. 2001;108(9):1633–1637
  25. Hui JI, Fishler J, Karp CL, Shuler MF, Gedde SJ. Retained nuclear fragments in the anterior chamber after phacoemulsification with an intact posterior capsule. Ophthalmology. 2006;113(11):1949–1953
  26. Liu Y, Luo L, He M, Liu X. Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients. Eye. 2004;18(9):900–904
  27. Kruger AJ, Schauersberger J, Petternel V, Arnon M. Inflammation after phacoemulsification in patients with type 2 diabetes mellitus without retinopathy: prospective study. J Cataract Refract Surg. 1999;25(2):227–232
  28. Doft BH, Wisniewski SR, Kelsey SF, Fitzgerald SG Endophthalmitis Vitrectomy Study Group. Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol. 2001;119(5):650–656
  29. Estafanous MF, Lowder CY, Meisler DM, Chauhan R. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol. 2001;131(5):620–625
  30. Hooper PL, Rao NA, Smith RE. Cataract extraction in uveitis patients. Surv Ophthalmol. 1990;35(2):120–144
  31. Zaborowski AG, Quinn AG, Dick AD. Cataract surgery in pediatric uveitis. J Pediatr Ophthalmol Strabismus. 2008;45(5):270–278
  32. Jancevski M, Foster CS. Cataracts and uveitis. Curr Opin Ophthalmol. 2010;21(1):10–14
  33. Bosch-Driessen LH, Plaisier MB, Stilma JS, Van der Lelij A, Rothova A. Reactivations of ocular toxoplasmosis after cataract extraction. Ophthalmology. 2002;109(1):41–45
  34. Yeung SN, Blicker JA, Maberley DA. Postoperative inflammation as the presenting sign of latent syphilis. Ocul Immunol Inflamm. 2008;16(3):119–120
  35. Al-Mezaine HS, Al-Assiri A, Al-Rajhi AA. Incidence, clinical features, causative organisms, and visual outcomes of delayed-onset pseudophakic endophthalmitis. Eur J Ophthalmol. 2009;19(5):804–811
  36. Clark WL, Kaiser PK, Flynn HW, Belfort A, Miller D, Meisler DM. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology. 1999;106(9):1665–1670
  37. Wykoff CC, Flynn HW, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008;115(9):1501–1507
  38. Kunimoto DY, Das T, Sharma S, et al. Endophthalmitis Research Group Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Am J Ophthalmol. 1999;128(2):240–242
  39. Aaberg TM, Flynn HW, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey (A 10-year review of incidence and outcomes). Ophthalmology. 1998;105(6):1004–1010
  40. Song A, Scott IU, Flynn HW, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109(5):985–991
  41. Apple DJ, Mamalis N, Loftfield K, et al. Complications of intraocular lenses (A historical and histopathological review). Surv Ophthalmol. 1984;29(1):1–54
  42. Arthur SN, Wright MM, Kramarevsky N, Kaufman SC, Grajewski AL. Uveitis-glaucoma-hyphema syndrome and corneal decompensation in association with cosmetic iris implants. Am J Ophthalmol. 2009;148(5):790–793
  43. Castiblanco CP, Adelman RA. Sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol. 2009;247(3):289–302
  44. Galor A, Davis JL, Flynn HW, et al. Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol. 2009;148(5):704–710
  45. O'Donoghue E, Lightman S, Tuft S, Watson P. Surgically induced necrotizing sclerokeratitis (SINS)—precipitating factors and response to treatment. Br J Ophthalmol. 1992;76(1):17–21
  46. Jhanji V, Yohendran J, Constantinou M, Sheorey H, Vajpayee RB. Scedosporium scleritis or keratitis or both: case series. Eye Contact Lens. 2009;35(6):312–315
  47. Nielsen JS, Blatt S, Perlman JI, Gieser RG. Clinicopathologic case report: scleral buckle associated nontuberculous mycobacterial scleritis. Semin Ophthalmol. 2004;19(3–4):101–104
  48. Schwartz A. Chronic open-angle glaucoma secondary to rhegmatogenous retinal detachment. Am J Ophthalmol. 1973;75(2):205–211
  49. Matsuo N, Takabatake M, Ueno H, Nakayama T, Matsuo T. Photoreceptor outer segments in the aqueous humor in rhegmatogenous retinal detachment. Am J Ophthalmol. 1986;101(6):673–679
  50. Matsuo T. Photoreceptor outer segments in aqueous humor: key to understanding a new syndrome. Surv Ophthalmol. 1994;39(3):211–233
  51. Bronner G, Zarbin MA, Bhagat N. Anterior ischemia after posterior segment surgery. Ophthalmol Clin North Am. 2004;17(4):539–543

PII: S0002-9394(10)00268-0

doi: 10.1016/j.ajo.2010.04.012

American Journal of Ophthalmology
Volume 150, Issue 3 , Pages 295-304.e1 , September 2010